Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

CardioCell

- PMLiVE

Allergan and Editas claim a CRISPR first in inherited blindness study

Partners are first to use CRISPR to edit cells inside the body

- PMLiVE

Keytruda hits primary endpoint in confirmatory lymphoma trial

Interim analysis demonstrates improvement in progression-free survival

Roche Basel Switzerland

China backs use of Roche’s Actemra for coronavirus

Anti-inflammatory drug will be used in patients with lung complications

- PMLiVE

Q&A: Mike Dixon

PME interviews the CEO of the Healthcare Communications Association (HCA)

HARNESSING TECHNOLOGY TO TRANSFORM HEALTHCARE IN THE DIGITAL AGE

THE IMPACT OF TECHNOLOGY IN HEALTHCARECutting-edge technology is rapidly changing the healthcare landscape. When you look closely at the rate and level of innovation brought about by tech over the...

Say Communications

- PMLiVE

Mergers and acquisitions: agents for change

Getting the best from your agency in a disruptive time

Bedrock Healthcare Communications

Keeping calm and carrying on: COVID-19 and approaches to CME/CPD during a viral outbreak

Celeste Kolanko, Managing Director, Liberum OPEN Health

OPEN Health

- PMLiVE

Alnylam scores EU approval for RNAi drug Givlaari

Company says it will work towards value-based agreements for the drug

- PMLiVE

BMS partners with Voluntis to co-develop oncology digital therapeutics

Aims to create a mobile app to help patients self-manage their symptoms

- PMLiVE

AbbVie says Allergan takeover delayed by FTC verdict

Merger now likely to complete in second quarter rather than first

- PMLiVE

Promoting enthusiasm and scientific expertise at Porterhouse Medical

Porterhouse Medical Group is delighted to announce that Beth Wynne-Evans has been promoted to Senior Medical Writer.Beth makes an important and vibrant contribution to our scientific services solutions at Porterhouse....

Porterhouse Medical Group

- PMLiVE

India’s export curbs raise fears of global drug shortages

Decision comes amid increased concerns over coronavirus outbreak

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links